Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer

J Surg Oncol. 2022 Jan;125(1):57-63. doi: 10.1002/jso.26740.

Authors

Jason M Foster¹, H Richard Alexander², Chunmeng Zhang¹

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
² Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

PMID: 34897714
DOI: 10.1002/jso.26740

No abstract available

Keywords: CRS/HIPEC; colorectal cancer; peritoneal metastases; treatment; trials.

Publication types

Editorial

MeSH terms

Clinical Trials, Phase III as Topic
Colorectal Neoplasms / pathology
Colorectal Neoplasms / therapy*
Cytoreduction Surgical Procedures
Humans
Hyperthermic Intraperitoneal Chemotherapy
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*
Randomized Controlled Trials as Topic